MannKind | MNKD - Ebit





Ebit Cambiamento Data
Adma Biologics USD 53.66M 5.57M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Eli Lilly USD 13.09B 635M 2026-09
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Insmed USD -81.83M 19.48M 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
MannKind USD -59.44M 8.79M 2026-09
Merck USD 7.33B 6.49B 2026-09
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Novavax USD 20.94M 100.32M 2025-12
Novo Nordisk DKK 5.25B 60.42B 2026-06
Pfizer USD 4.85B 5.03B 2026-09
Sanofi EUR 4.72B 3.6B 2026-09
Xencor USD -36.6M 41.26M 2026-06